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Abstract: 
Artemisinin, an antimalarial treatment derived from Artemisia annua, reacts with ferrous 
compounds, generating free radicals unless hindered by antioxidants. High iron levels and low 
antioxidant levels of cancer cells make artemisinin a potentially effective treatment. We utilized 
MTT assays to assess artemisinin’s effect on MCF7 breast cancer cells. Artemisinin upregulated 
cell proliferation and appeared to affect the cells’ morphology, which could impact tumor 
development.  
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Introduction: 
There have been several studies and compelling research conducted regarding the effect 
artemisinin has on the proliferation of breast cancer cells. It is estimated that around 1 in 8 
women in the United States will have breast cancer at least once in their lifetime (U.S., 2016). 
Breast cancer is the second most diagnosed cancer in women in the United States, behind skin 
cancer (U.S., 2016). Breast cancers that are sensitive to estrogen can be treated with 
antiestrogens that do not contain steroids (Sundar et al, 2008), however these can have severe 
side effects. Breast cancers that are not responsive to estrogen are currently treated through 
surgery to remove the tumors, or chemotherapy (Sundar et al, 2008). Researchers are now 
looking at plant compounds utilized for other medicinal purposes as potential natural treatments 
for certain types of breast cancer. Specifically, researchers have been focusing on the malaria 
treatment that utilizes Artemisia annua, whole plant and extract, due to its selectivity for cancer 
cells and its low toxicity toward normal cells (Su et al., 2015). Thus, we examined the effects of 
these treatments, and the purified active ingredient artemisinin, on the breast cancer cell MCF7 
as a model.  
Artemisia annua contains a multitude of chemical compounds that can influence 
metabolic pathways. A study performed in 2008 studied the relative antioxidant and nutrient 
levels in Artemisia annua to assess the nutritional balance and chemical composition of the plant 
and quantify its viability as a potential herbal tonic and treatment (Brisibe et al, 
2008).  Experimenters grew A. annua plants in specified conditions and studied their 
composition among different tissues within the plant to identify chemical concentrations and 
variations. Researchers determined that A. annua leaves, the most common part of the plant 
utilized to brew teas used in disease treatments, have a relative protein content of 27.1%, 
compared to a mere 8.23% value found in roots (Brisibe et al, 2008). When analyzing mineral 
and amino acid values in different tissues, researchers concluded that leaves and inflorescence 
had the highest values of nearly all minerals, and leaves having significantly higher levels of 
amino acids (Brisibe et al, 2008). Finally, researchers studied antioxidant capacities, with 
antioxidants being vital to the mitigation of free radical production in organisms. The results 
illustrate that leaves being utilized to brew artemisinin teas have a wide range of additional 
compounds that may influence metabolic pathways in the organism or vector being exposed 
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(Brisibe et al, 2008). The focus of this particular study will then take into consideration the 
medicinal value of the Artemisia annua plant as well as the purified artemisinin compound.  
Artemisinin and its derivatives cause the proliferation of free radicals when they react 
with iron compounds. This free radical proliferation allows for the destruction of infectious 
agents like malaria, which utilize host iron supplies (Torti et al, 2013). Despite being incredibly 
toxic to malaria producing protozoa, artemisinin seems to have little to no detrimental effect on 
the human body due to the presence of antioxidant enzymes. These enzymes may work to 
prevent the activity of free radicals, rendering them less detrimental to human somatic cells. 
While vital to the immune system, antioxidant presence in cancer cells could hinder the 
effectiveness of artemisinin as a treatment method, as the enzymes would prevent the free 
radicals from causing apoptosis (Cui et al, 2009). However, the direct mechanism of action of 
artemisinin in regard to this potency compared to traditional cancer therapeutic agents is still 
being determined (Lai et al., 2013). 
Thus, studies were performed in order to understand the presence of antioxidants in 
cancer cell lines. One study utilized a wide variety of biochemical analyses to determine variance 
in antioxidant levels of different strains of cancer. Researchers performed in vivo experiments by 
stimulating estrogen induced hamster kidney tumors and then measuring endogenous antioxidant 
levels. Researchers then compared these antioxidant levels to those of control models to draw 
conclusions on how cancer affects antioxidant presence. Compared to the control tissues, nearly 
all cancers were found to have lower levels of several antioxidants, namely manganese 
superoxide dismutase, zinc superoxide dismutase and catalase, among several other superoxide 
dismutases. The data suggest that the utilization of antioxidants is decreased in cancer cells 
(Oberley and Oberley, 1997). 
 Researchers also focused on the effect iron levels had on cancer growth and development, 
as well as how regulation of these levels affect cellular processes within the body (Torti et al, 
2013). It was observed that an abundance of transferrin (TF) receptors on the outside of cells 
mediate the uptake of iron compounds, and that increasing levels of TF receptors correlated 
directly with an increase in tumor development among patients. Further evaluations into the 
effects of dietary iron intake and accumulation in cells among the patients studied supported 
these initial conclusions. As well, it was observed that a reduction of iron stores within cancer 
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patients over time correlated directly with a decrease in cancer (Torti et al, 2013). This was 
shown through a long term experiment where over the course of 4.5 years, elderly men with 
peripheral artery diseases repeatedly donated blood (Torti et al, 2013). The results indicated that 
overall cancer risk and cancer-specific mortality was reduced. When comparing cancer lines to 
benign tissues, the study also demonstrated that the cancerous cell lines had higher levels of 
transferrin with respect to their normal counterparts (Torti et al, 2013). 
To study the effects of artemisinin on cancer cells with respect to iron levels, researchers 
cultured Molt-4 cells with holotransferrin to bolster the cellular iron levels (Lai et al, 2004). 
According to their results, the presence of artemisinin directly correlated with a decrease in cell 
count. Experimenters utilized dihydroartemisinin (DHA), an artemisinin derivative, to study the 
effects of the compound on cells. Experimenters set up groups exposed to no compounds, 
transferrin, DHA, and both test compounds to study their effects and synergies. There was little 
variation between the control group and transferrin groups, while the DHA exposed groups 
showed a significant drop in cells present. Moreover, the DHA and transferrin group showed a 
much greater drop in cell counts, down to near 0% cell counts after 8 hours of incubation.  In 
addition, cellular apoptosis rates also showed dramatic variation depending on treatment methods 
utilized, with nearly 30% of the DHA and transferrin cells undergoing apoptosis by 8 hours with 
a steadily increasing rate until that point in contrast to the only 5% from the control groups that 
was consistently maintained throughout the trials. The high rate of apoptosis strongly supports 
the researchers’ claims that artemisinin is able to interfere with cancer growth, and its presence is 
particularly effective when bolstered by higher cellular iron levels (Lai et al, 2004).  
In another study, polyphenols from Korean Artemisia annua L (pKAL) were isolated and 
their effects on MDA-MB-231 breast cancer cells were examined. Specifically this study focused 
on the adhesion of cancer cells to the endothelial cell and epithelial-mesenchymal transition 
(EMT), which is a process considered to facilitate metastasis. Through various assays (including 
adhesion, Matrigel invasion, and cell viability, along with gelatin zymography and western 
blotting) the researchers were able to see that pKAL inhibited the breast cancer cells from 
adhering to the endothelial cells of human blood vessels through suppressing the expression of a 
cell adhesion protein (VCAM-1), thus interfering with the EMT process (Ko et al., 2016). It is 
also important to note that, this study demonstrated that polyphenols derived from pKAL had 
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very little toxic effect on cells that were not the MDA-MB-231 breast cancer cells (Ko et al., 
2016). In order for this to be an effective treatment, though, further investigations into the effects 
of artemisinin on cancer cells need to be performed.  
Using a different approach, a study in 2014 compared the effectiveness of Artemisia 
annua tea versus purified artemisinin as a cancer treatment for the MCF7 breast cancer cell line. 
It has been shown in vitro that metabolites of the tea are able to work with artemisinin increasing 
antiplasmodial activity (Suberu et al., 2014). A majority of the co-metabolites present in 
Artemisia annua tea are chlorogenic acids, also known as caffeoylquinic acids (CQAs). Similar 
to the polyphenols in the previous study, CQAs can act as antioxidants, and they also possess the 
ability to act against bacteria and histamines (Suberu et al., 2014). Furthermore, CQAs have been 
found to disrupt the RAB oncogene in human breast cancer cells through blocking of the 
methylation of the promoter region (Suberu et al., 2014). The researchers in this study chose to 
look at how chlorogenic acid (3-caffeoylguinic acid, 3CA) and Artemisia hot water infusion (tea) 
work as a treatment against MCF7 cancer cells compared to cisplatin, an anticancer compound. 
The results illustrated, using the percent of cell survival and the molarity of anticancer agent 
used, that cisplatin had much greater cytotoxic effects than artemisinin (Suberu et al., 2014). 
Combining artemisinin with 3CA at a 1:1 molar ratio caused a large decrease in cytotoxicity, 
while combining cisplatin with 3CA at a 1:1 molar ratio caused 2.5-fold increase in cytotoxicity 
over cisplatin by itself (Suberu et al., 2014). These results suggest that Artemisia annua tea may 
not be an effective anticancer therapy.  
Artemisinin causes the level of free radicals to increase, however free radicals can be 
inhibited by antioxidants. Therefore, the high iron levels and low antioxidant levels of cancer 
cells makes artemisinin an interesting compound to pursue in the hopes to provide a natural 
cancer therapy for patients. Based on the literature, we developed the following hypotheses to 
research artemisinin’s anti-proliferative effects. First, we predicted that artemisinin will inhibit 
the proliferation of MCF7 cells due to the high iron levels and low antioxidant levels present in 
these cancer cells. Our second hypothesis was that: pure artemisinin will be a more effective 
tumor therapy than whole plant extract due to additional antioxidants present in Artemisia annua 
that may interfere with the anti-proliferative effect of artemisinin on MCF7 cells.  
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Methodology: 
 
Pure Artemisinin Solution 
A pure artemisinin solution was made from Sigma- Aldrich artemisinin (Product #361593) to a 
final concentration of 12.5 mM stock in 100% EtOH. 
 
Artemisia annua Tea Preparations 
Following the protocol outlined in Subaru (2014) with slight modifications, water brewed tea 
was prepared by boiling water 1 liter and pouring it over 5 grams of dried, crushed Artemisia 
annua leaves to steep for 20 minutes. The Artemisia annua water brewed tea was then sterile 
filtered, and stored at 4℃. Ethanol brewed tea was prepared by macerating 1 gram of the dried 
Artemisia annua leaves, and adding it to 200 mL of 70% EtOH in water, then incubated on a 
shaker at room temperature overnight. The Artemisia annua ethanol brewed tea was then sterile 
filtered, and the ethanol was allowed to evaporate overnight, and the dry extract was resuspended 
in 200 mL of water (Suberu, J.O., et al., 2014). 
 
Cell Culture: MCF7 Cell Line 
MCF7 cells were maintained at 37℃ until they reached about 75% confluence at which time 
they were passaged 1:5 by trypsinization (Tchafa, A. M, et al., 2013). Cell counts were obtained 
using a Nexcelom Bioscience Cellometer® Auto T4 and 1% Trypan blue viability stain. MCF7 
cells were grown in two types of media depending on the experiment. The first media, “Insulin” 
was made from Dulbecco’s Modification of Eagle’s Medium (DMEM), 10% fetal bovine serum 
(FBS), 1% Penicillin/ Streptomycin (P/S), and 0.01 mg/mL bovine pancreas insulin (MCF7 
(ATCC® HTB-22™)). The second media, “White,” was made by combining phenol red free 
DMEM, 10% dextran charcoal stripped FBS, and 1% P/S (Vybrant® MTT Cell Proliferation 
Assay Kit). 
 
MTT Assays 
MCF7 cells were plated at 1 x 104 cells per 200 uL media /well in a 96 well plate and cultured 
for 24 hours in insulin medium as described previously (Vybrant® MTT Cell Proliferation Assay 
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Kit). In order to determine estrogen responsiveness, triplicate samples were treated with estrogen 
for 24 hours at either 2mM, 10mM, or 100 mM (1% total volume of ethanol per well) in phenol 
red free medium with untreated and EtOH controls. For artemisinin dose response testing, 
triplicate samples were treated with artemisinin for 24 hours at 5uM, 25uM, 50uM, 75uM, and 
100 uM (1% total volume of ethanol per well) with an untreated sample as a control. A second 
dose response experiment was subsequently performed the same method previously described, 
with a different range of artemisinin concentrations: 25 uM artemisinin, 15 uM artemisinin, 5 uM 
artemisinin, and 2.5 uM artemisinin. Time course experiments were performed with triplicate 
samples treated with 15 uM artemisinin with incubation times of 24, 18, and 12 hours. Finally, to 
compare the effects of  artemisinin and Artemisia annua tea,  triplicate samples were treated with 
15 uM artemisinin, 5 %, 7.5%, 10%, and 15% Artemisia annua tea (v/v) brewed in ethanol, and 
5%, 7.5%, 10%, and 15% Artemisia annua tea (v/v) brewed in water with untreated and EtOH 
controls. It is important to note that the final concentration of ethanol in these samples were 
above the previously designated 1% per well since the tea was diluted in 70% ethanol originally. 
After another 24 hour incubation period, Promega CellTiter 96 Aqueous One Solution Cell 
Proliferation Assay (MTT) reagent was added to each of the wells and incubated for four hours 
in 37℃ (CellTiter 96® AQueous One Solution Cell Proliferation Assay System Protocol). Then 
the plate was read at 570 nm utilizing a BioTech Instruments® EL800 Microplate reader. Each 
MTT assay experiment (estrogen responsiveness, dose response, time course, and artemisinin vs. 
tea) was repeated twice as described above. Samples run in triplicate were averaged, and 
expressed as percent control. Due to small sample size (N=2), statistical analysis was not 
performed. 
 
HPLC 
High Pressure Liquid Chromatography (HPLC) was performed utilizing an Agilent 1100 Series 
HPLC system. Using the method of Ferreira et al, ultraviolet detection with a wavelength of 192 
nm, bandwidth 3, and a reference wavelength of 592 nm, reference bandwidth 100, were used 
while running a C-18 column at a flow rate of 1 ml/min under isocratic conditions of 60% 
Acetonitrile/ 40% aqueous (0.1%) acetic acid. Between sample injections, the mobile phase 
(which was run for five minutes) and the data collection window (which was run for 15 minutes) 
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had a flow rate of 1mL/min (Ferreira, J.F., et al., 2009). Samples of 10 uL were analyzed, and 
elution times were used to identify and quantify peaks and confirm the eluted compound. The 
tested samples were 12.5 mM stock pure artemisinin, 5 uM artemisinin, 50 uM artemisinin, 100 
uM artemisinin, Artemisia annua tea brewed in water, Artemisia annua tea brewed in ethanol. 
The water brewed and ethanol brewed Artemisia annua teas were then both spiked with pure 
12.5 mM stock pure artemisinin and ethanol to identify the solvent peak. A standard curve was 
created using the pure artemisinin concentration and the area under the peak. The determined 
linear line of best fit was then used to approximate the levels of artemisinin in Artemisia annua 
tea samples. 
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Results: 
Please refer to Appendices A-F for the raw data compiled throughout all experiments. 
 
Estrogenic Response 
A MTT assay was performed as previously described in order to determine if the MCF7 
cell culture used in this study was estrogen responsive. The absorbance values for the pure media 
wells were subtracted from the values of the experimental wells. These new values were then 
averaged, compared to the positive control cells, MCF7 cells grown with no added estrogen. The 
data is expressed as percent control (refer to Figure 1 below).  
 
Figure 1: MTT assay (N=2) estrogenic response results for cells treated with ethanol, and 2mM, 
10mM, and 100mM concentrations of estrogen. 
 
As seen in Figure 1, there is a general trend decreasing the amount of cell proliferation compared 
to the control cells across the experimental treatments. Ethanol demonstrated about a 10% 
difference compared to control MCF7 cells, while the various dilutions of estrogen showed about 
a 20% decreased compared to the positive control. However, due to small sample size (N =2) and 
large variability in triplicate measures, no conclusion can be reached about the effect of estrogen 
on cell proliferation. Overall, the data consistently showed that the MCF7 cells appeared to have 
no proliferative response when exposed to various concentrations of estrogen, especially in 
comparison to the positive control. 
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Dose Responsiveness Artemisinin 
An MTT assay was performed, as previously described, in order to determine the 
effective dose of pure artemisinin on MCF7 Breast Cancer cells. Figure 2 below then represents 
the initial trials of the dose response testing.  
 
Figure 2: MTT assay (N=2) initial artemisinin dose response results for cells treated with 5 uM, 
25 uM, 50 uM, 75 uM, and 100 uM concentrations of artemisinin.  
 
The results in Figure 2 do not conclusively demonstrate a difference in the response to doses of 
artemisinin from 5 uM to 100 uM; however, we observed an apparent plateau when cells were 
exposed to artemisinin concentrations higher than 25 uM. Thus, this procedure was repeated with 
decreased artemisinin concentrations: 25 uM, 15 uM, 5 uM, and 2.5 uM artemisinin (see Figure 
3). 
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Figure 3: MTT assay (N=2) second artemisinin dose response results for cells treated with 2.5 
uM, 5 uM, 15 uM, and 25 uM concentrations of artemisinin. 
 
Once again, the results in Figure 3 do not demonstrate a dose dependent response, although there 
appears to be a possible increase in cell number as compared to untreated controls, albeit 
somewhat less than the increase shown in Figure 2. We chose to pursue artemisinin at a 
concentration of 15 uM for future experiments in this study because 25 uM artemisinin caused a 
relatively higher proliferative effect than the lower doses. 
 
Artemisinin Time Course 
Results of a time course, performed as described in Methods, are shown in Figure 4 
below.  
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Figure 4: Time course experiment (N=2) over intervals of 12 hours, 18 hours, and 24 hours 
treated with 15 uM artemisinin.  
 
The results presented in Figure 4 demonstrate an apparent difference in growth after 24 hours in 
15 uM artemisinin. Thus, 24 hours and 15 uM artemisinin were used in subsequent experiments. 
 
HPLC 
High pressure liquid chromatography (HPLC) was performed to identify artemisinin in 
both pure substance and plant extract. Both ethanol and water brewed A. annua tea were tested to 
determine artemisinin content in the two preparations. A representative chromatogram is shown 
in Figure 5.  
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Figure 5: Sample of HPLC results for 12.5 uM stock pure artemisinin demonstrating the peak for 
ethanol at 3 minutes and the peak for artemisinin at 5.4-5.5 minutes (Ferreira, J.F., et al., 2009). 
 
Table 1 below summarizes the areas under the artemisinin peak, as determined above, for 
pure artemisinin and A. annua teas tested by HPLC.  
Table 1: HPLC results for artemisinin and A. annua teas (each various concentration of 
artemisinin was sampled at the same volume of 200uL)    
Test group Area (mAU*s) Time of elution (minutes) 
Artemisinin 5 uM 136.6 5.5 
Artemisinin 25 uM 575.4 5.5 
Artemisinin 50 uM 2391.5 5.4 
Artemisinin 75 uM 1631.1 5.5 
Stock artemisinin 12.5 mM 5282.5 4.4 
Tea brewed in water (1) 43.9 5.5 
Tea brewed in water (2) 32.0 5.4 
Tea brewed in EtOH (1) 30.4 5.4 
Tea brewed in EtOH (2) 50.1 5.5 
Tea brewed in EtOH with 2.5mM artemisinin 512.1 5.5 
Tea brewed in water with 2.5mM artemisinin 332.4 5.5 
 
Using several concentrations of artemisinin, as well as teas spiked with artemisinin, it 
was concluded that artemisinin elutes at approximately 5.4-5.5 minutes (Ferreira, J.F., et al., 
2009). This time of elution was used to identify peaks due to artemisinin in tea samples, although 
there was a poor correlation between artemisinin concentration and peak, a best fit plot was 
constructed (see Figure 6) and used to calculate approximate artemisinin concentrations in the 
two teas. 
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Figure 6: Artemisinin concentration in Artemisia annua tea with respect to HPLC recorded 
areas of trials tested in this study (note: the more trials performed at different concentrations, 
the more accurate the trend line and predictions will be). 
 
When using the above denoted equation (y=0.0235x+10.912 where “x” represents the calculated 
area and “y” represents the calculated artemisinin molarity), the calculated tea values seemed 
disproportionately high (12 uM for the average EtOH tea and water brewed tea). It is also 
apparent that the values for the two teas fall well below the range of the standard curve. To re-
approximate the molarity of the two tea values, a proportion of the peak area for 5 uM 
artemisinin was calculated using the peak areas for the two samples, resulting in approximately 
1.5 uM artemisinin in EtOH brewed tea and 1.4 5 uM artemisinin in water brewed tea. 
 
Artemisia annua Tea vs. Pure Artemisinin  
An MTT assay was performed as outlined in the methodology in order to determine the 
effectiveness of Artemisia annua tea brewed in both ethanol and water on MCF7 breast cancer 
cells. Morphologically, there was a noticeable difference between cells grown in regular media 
and those treated with 15 uM artemisinin (see Figure 7). The MCF7 cells incubated in regular 
media (left) are adhered to the plate, as well as flat in appearance, as expected; while the cells 
incubated in the artemisinin are rounded up (right).  
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Figure 7: (Left) Image of MCF7 cells incubated in media after 24 hours. (Right) Image of MCF7 
cells incubated in 15 uM artemisinin after 24 hours (400x magnification). 
 
As seen in Figure 8 below, demonstrating the MTT assay results for MCF7 cellular 
response when exposed to Artemisia annua tea, there is a noticeable difference from the control 
cells compared to cells incubated in the various percentages of Artemisia annua tea brewed in 
ethanol. However, ethanol alone appears to have an equivalent effect.  There is an average 
decrease of about 50% in the cellular proliferation overall. By contrast, cells grown in Artemisia 
annua tea brewed in water, show average increase in cell number of about 18%.when compared 
to untreated controls the result of the cells treated with 15 uM pure artemisinin was also similar 
to the tea brewed in water results.  
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Figure 8: MTT assay (N=2) MCF7 cells treated with an array of EtOH and H2O teas containing 
5%, 7.5%, 10%, and 15% artemisinin, as well as 15uM pure artemisinin and 1% EtOH as a 
negative control. 
 
As previously mentioned in the methodology section, the final concentration of the ethanol in the 
Artemisia annua tea samples for both water and ethanol brewed were higher than the 1% 
designated per well. This was due to the tea originally being placed in 70% ethanol, and when 
added to the wells of the experiment, the 15% tea medium resulted in over 10% ethanol per well. 
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Discussion: 
The literature describes MCF7 cells as able to express high levels of the alpha estrogen 
receptor, therefore estrogen should stimulate the growth of this cell line (Lee et al., 2015). 
However, the MTT assays for the estrogenic response yielded no conclusive results since only 
two trials were performed and aggregated, allowing no statistical analysis to be done. As well, 
the variability among the replicates was so high as to negate any direct interpretation of the 
results. Overall though, there are consistent aspects of the data that may be addressed in regard 
to: artemisinin’s effect on cellular proliferation, the minimal amount of artemisinin in Artemisia 
annua tea, and morphological effects of artemisinin on MCF7 cells. 
Although artemisinin does not seem to have a clear impact on cellular proliferation as 
indicated by the contrasting results in literature, and our results from this study; there is 
indication that it may have a slight proliferative effect. Our results for MCF7 cells exposed to 
artemisinin in the dose response trials had higher cellular counts than the control group up to 25 
uM artemisinin, where our data consistently demonstrated that the proliferation plateaus, 
suggesting this dose as a possible threshold. In hindsight though, we believe that using a higher 
concentration (such as 25uM) where cell proliferation increases noticeably, could be effective in 
further understanding what role artemisinin can play in proliferation. 
In addition, our results indicated that while there were no noticeable changes at the 12 
and 18 hour mark in the time course when exposed to artemisinin, at the 24 hour interval cells 
exposed to artemisinin had a much higher level of cellular proliferation. We believe that our cells 
did not have any observable differences during the first two time intervals because the cells had 
not completely undergone a mitotic cycle at those times. Thus, artemisinin may have an effect on 
cellular proliferation based on exposure and time available for mitotic divisions.   
When the Artemisia annua tea was brewed in ethanol it consistently had the greatest 
effect on the decrease in cellular proliferation. When the tea was brewed in water, the cells 
seemed to increase in proliferation at a similar rate to 15uM pure artemisinin. Overall, the MCF7 
cells that were exposed to 15% Artemisia annua tea brewed in ethanol exhibited the largest 
decrease in cell proliferation. One explanation for these results could be that the level of 
artemisinin that the cells were exposed to was too low to have a significant effect on cellular 
proliferation. Moreover, to reach an artemisinin concentration equivalent to 15 uM pure 
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artemisinin media, large amounts of ethanol brewed tea needed to be added to media. At the 15 
uM equivalent, the test media was approximately 10% ethanol. This high level of alcohol could 
kill a large portion of the cells, resulting in an inaccurate reading of the tea’s role in proliferation. 
Our hypothesis also predicted that artemisinin values would be higher in ethanol tea than water 
tea since artemisinin is soluble in alcohol, and our data does not support our hypothesis. We did 
not observe any noticeable differences between the two types of tea with respect to artemisinin 
concentration. We observed noticeable differences in tea composition aside from artemisinin 
content, with several compounds eluting in different concentrations. This finding could be due to 
several factors. One primary factor could be that, while ethanol acts as a much more effective 
solvent for pure artemisinin, compounds in the plant aside from artemisinin could affect how the 
solvent functions in dissolving compounds. Another key factor could be that the dried plant leaf 
that we used simply had low levels of artemisinin in it, so the variance between the effectiveness 
of the solvents could not be discerned through HPLC readings of the tea. This can explain why, 
in addition to having so many other eluting compounds within the tea, the artemisinin readings 
themselves were so low. 
When utilizing pure artemisinin to create a trend line, we calculated a set of outlier values 
at the 50 and 75uM concentrations. Due to the limited HPLC calculations that we performed, we 
were not able to effectively assess the variance in these data points, which could influence the 
final values determined for approximate artemisinin concentrations within the two teas. We 
believe this outlier value was due to sampling errors that could have occurred when performing 
HPLC, leading to a relatively higher amount of artemisinin in the extracted 50uM sample or a 
relatively low extracted amount in the 75uM sample. By performing several replications of these 
readings, a more concise trend line can be calculated to eliminate potential outliers and produce a 
more accurate trend line for calculating artemisinin concentrations. Moreover, by measuring 
artemisinin elution values at concentrations lower than 5uM, we may more accurately determine 
the trend line and the amount of artemisinin in Artemisia annua tea.  
Finally, we observed throughout the MTT assay experiments that cells exposed to 
artemisinin seemed to be rounded in shapes that resembled cells in trypsin, and were not growing 
in larger masses as readily as control cells. While the cells were not apparently suspended in the 
test media, their morphology and growth patterns suggest that they were not exhibiting behaviors 
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of cancer cells forming larger tissues. It is possible that the when the cells were viewed under the 
microscope, they were in a stage of mitosis that caused the shape change. It would be beneficial 
to view the cells during different growth stages and compare the morphologies to better 
understand whether the shape change was from artemisinin or due to the stage of the growth they 
were currently in. However, if cells are unable to plate down, in theory they may not be able to 
metastasize and form a tumor. This has been shown through cell adhesion studies, such as the 
2016 study which concluded that Korean Artemisia annua L (pKAL) suppressed the expression 
of a cell adhesion protein, therefore breast cancer cells were unable to attach to the endothelial 
lining of blood vessels (Ko et al., 2016). The results of this paper suggested that pKAL could be 
a potential form of therapy against cancer metastasis (Ko et al., 2016). 
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Conclusions & Recommendations: 
We concluded that we have not produced any evidence that supports the claim of 
artemisinin as a cancer therapy, as our results were not able to be statistically analyzed and cell 
counts did not seem to be affected. Due to this conclusion, we have developed the following 
recommendations for future studies regarding artemisinin’s potential as a natural cancer 
therapeutic in areas of: materials used, procedures performed, and topics to explore.   
Since the MCF7 cells did not seem to respond to estrogen, a compound known for 
increasing proliferation in MCF7 cells, we recommend that future experimenters utilize an array 
of different cell lines when studying artemisinin. As well, we recommend that future studies 
should compare cellular proliferation levels against those of previously tested compounds with 
known effects to comparatively assess the testability of their cells and the artemisinin treatment. 
In addition, a recommendation for the Artemisia annua tea versus artemisinin experiment is to 
use dimethyl sulfoxide (DMSO) as the solvent so that it will not kill the cells and can be ruled 
out as a confounding variable. Since DMSO does not affect cells as adversely as ethanol, it could 
be used as a potential solvent when attempting to brew teas that can be added at higher quantities 
to test mediums. 
Along with this, we recommend utilizing a different method to quantify the concentration 
of cells in each well aside from or in addition to the MTT Assay. MTT Assays are able to detect 
viable cells, however they do not specifically detect cellular proliferation (Riss et al., 2016). 
Using an assay to assess the amount of damaged DNA within a well could be utilized to quantify 
apoptosis levels, rather than simply measuring the total amount of DNA within the wells.    
We noticed that cellular morphology changed when cells were exposed to artemisinin, 
therefore we recommend that future experimenters assess the adhesion of cells exhibiting this 
behavior to understand how this phenomenon can be used in potential therapies, such as 
hindering the formation of more complex tissues or lowering the potential for metastatic cells to 
adhere and grow into additional tumors. If this morphological change affects cellular adhesion 
factors, it would prevent cells from successfully attaching to somatic tissues and developing into 
tumors. We suggest that future experimenters develop in vitro experiments to model cellular 
adhesion and metastatic properties to identify potential benefits and consequences of this as a 
treatment option. We also suggest that future researchers investigate specific cell adhesion 
factors and how they may change when exposed to artemisinin.   
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Appendices 
 
Appendix A. 
Estrogenic Response Raw Data (Absorbance Values at 570 nm) 
Trial #1 & 2 
   
 
Appendix B. 
Artemisinin Dose Response Initial Raw Data (Absorbance Values at 570 nm) 
Trial #1 & 2 
  
 
Appendix C. 
Artemisinin Dose Response Secondary Raw Data (Absorbance Values at 570 nm) 
Trial #3 & 4 
  
 
Appendix D. 
Artemisinin Dose Response Time Course (Absorbance Values at 570 nm) 
Trial #1 
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Trial #2 
 
Appendix E. 
Artemisia annua Tea vs Artemisinin (Absorbance Values at 570 nm) 
Trial #1  
 
Trial #2 
 
 
Appendix F. 
HPLC Raw Results 
5 uM Artemisinin     25 uM Artemisinin 
  
50 uM Artemisinin     75 uM Artemisinin 
  
100 uM Artemisinin    12.5 mM Artemisinin 
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Artemisia annua Tea Brewed in Ethanol (1) Artemisia annua Tea Brewed in Ethanol (2) 
  
Artemisia annua Tea Brewed in Water (1) Artemisia annua Tea Brewed in Water (2) 
  
Artemisia annua Tea Brewed in Ethanol + 50 uL 12.5 mM Artemisinin  
 
Artemisia annua Tea Brewed in Water + 50 uL 12.5 mM Artemisinin 
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